CTSH Cognizant Technology Solutions Corporation Class A

SHAREHOLDER ALERT: Holzer & Holzer, LLC Reminds Investors of Upcoming Deadlines in Class Action Lawsuits Against Cognizant Technology Solutions, Tyson Foods and Cempra

Holzer & Holzer, LLC reminds investors that several lead plaintiff deadlines are approaching in class action lawsuits.

A lead plaintiff is a representative party appointed by the court to act on behalf of other class members in directing the litigation. Anyone who purchased shares during the relevant time may move the court to serve as lead plaintiff, but your ability to share in any potential recovery does not require you to become a lead plaintiff.

If you purchased the following securities during the referenced time periods, you are encouraged to contact Corey D. Holzer, Esq. via email at [email protected], or Marshall P. Dees, Esq. via email at [email protected], or you may call the firm toll free at (888) 508-6832, to discuss your legal rights.

Cognizant Technology Solutions Corp. (NASDAQ: CTSH)

A class action lawsuit has been filed on behalf of investors who purchased CTSH securities between February 25, 2016 and September 30, 2016. According to the complaint, Cognizant officials failed to disclose improper payments made by the company to gain permits and building licenses in India. Investors who wish to file a motion to become the lead plaintiff in the litigation must do so not later than December 5, 2016.

Tyson Foods, Inc. (NYSE: TSN)

A class action lawsuit has been filed on behalf of investors in Tyson Foods, Inc. who purchased TSN shares between November 23, 2015 and October 7, 2016. The lawsuit alleges Tyson Foods unlawfully conspired to fix chicken prices, which resulted in the Company misstating its financial results during that time. Investors who wish to file a motion to become the lead plaintiff in the litigation must do so not later than December 16, 2016.

Cempra, Inc. (NASDAQ: CEMP)

A class action lawsuit has been filed on behalf of investors who purchased CEMP common stock between May 1, 2016 and November 1, 2016. The lawsuit alleges Cempra omitted material facts when discussing its lead product candidate, solithromycin. Investors who wish to file a motion to become the lead plaintiff in the litigation must do so not later than January 3, 2017.

About The Firm

Holzer & Holzer, LLC is an Atlanta, Georgia law firm that dedicates its practice to vigorous representation of shareholders and investors in litigation nationwide. More information about the firm is available through its website, www.holzerlaw.com and upon request from the firm. Holzer & Holzer, LLC has paid for the dissemination of this promotional communication, and Corey D. Holzer is the attorney responsible for its content.

EN
17/11/2016

Underlying

Reports on Cognizant Technology Solutions Corporation Class A

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

Still No Decisive Breakout as SPX Tests 5783 The S&P 500 (SPX) remains just below 5783, which is the upper-end of an important target/resistance area we have discussed for over a month (5670-5783). 5670 was the prior all-time high set in July, while 5783 is 2% above 5670. It is hard to call it a "decisive" breakout if the SPX is not even 2% above its prior high, and, importantly, in 2007, the SPX made a top after climbing 1-2% above its prior high. To reiterate, the 2007 topping analog has trac...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch